Researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children.
Learn more about the research.
@YaleNephrology@YalePediatrics@JasonHenryG@fperrywilson
https://t.co/4TiDDcp9lz
In this study, three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD. https://t.co/3K5kf9PKRk
#ASNCJASN
Thrilled and very proud of @Nephronette who will be presenting the results of the Kidney Action Team Trial at #kidneywk in San Diego this month.
Did personalized, real-time recommendations for initial diagnosis and management of AKI (N=4,003) move the needle on AKI outcomes? Join us and find out!
Excited to share that our study on long-term outcomes after pediatric AKI (not treated with dialysis) was just published in @JASN_News.
Childhood AKI survivors were at >2x higher risk of long-term CKD, kidney failure, hypertension, and subsequent AKI.
https://t.co/wSgAZSq8dY
Woohoo!!! At long last, the #SUPERHERO_Registry is LIVE and published!
Check out our website: https://t.co/6aAJ5SGhpu
And our Methods paper:
https://t.co/v8C3EQpyPE
Thanks @AmJEpi@wakeforestmed@WFCTSI@WFBMI@WakePeds and all our sites and teammates!
Left ventricular hypertrophy (LVH) is linked to increased risk of cardiovascular disease & mortality. This study shows higher plasma & urine KIM-1, urine MCP-1, & lower urine alpha-1m were linked to LVH prevalence in children with CKD https://t.co/wgNdUJdIin
@SarahJSchrauben
AKI in children is assoc w/increased morbidity, reduced quality of life, greater resource utilization, & higher mortality. Read these Conf Proceedings on existing, novel, & pending diagnostic & risk-stratification tools for pediatric AKI. #OpenAccess
https://t.co/vNHI6p1Aye